nikos evangelou
nikos evangelou
Verified email at
Cited by
Cited by
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ...
The Lancet Neurology 15 (3), 292-303, 2016
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis
N Evangelou, MM Esiri, S Smith, J Palace, PM Matthews
Annals of Neurology: Official Journal of the American Neurological …, 2000
Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis
N Evangelou, D Konz, MM Esiri, S Smith, J Palace, PM Matthews
Brain 123 (9), 1845-1849, 2000
The current state-of-the-art of spinal cord imaging: methods
PW Stroman, C Wheeler-Kingshott, M Bacon, JM Schwab, R Bosma, ...
Neuroimage 84, 1070-1081, 2014
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis
N Evangelou, D Konz, MM Esiri, S Smith, J Palace, PM Matthews
Brain 124 (9), 1813-1820, 2001
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
P Sati, J Oh, RT Constable, N Evangelou, CRG Guttmann, RG Henry, ...
Nature Reviews Neurology 12 (12), 714-722, 2016
Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter …
CP Gilmore, I Donaldson, L Bö, T Owens, J Lowe, N Evangelou
Journal of Neurology, Neurosurgery & Psychiatry 80 (2), 182-187, 2009
The contribution of demyelination to axonal loss in multiple sclerosis
GC DeLuca, K Williams, N Evangelou, GC Ebers, MM Esiri
Brain 129 (6), 1507-1516, 2006
The current state-of-the-art of spinal cord imaging: applications
CA Wheeler-Kingshott, PW Stroman, JM Schwab, M Bacon, R Bosma, ...
Neuroimage 84, 1082-1093, 2014
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
L Matthews, R Marasco, M Jenkinson, W Küker, S Luppe, MI Leite, ...
Neurology 80 (14), 1330-1337, 2013
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
EC Tallantyre, JE Dixon, I Donaldson, T Owens, PS Morgan, PG Morris, ...
Neurology 76 (6), 534-539, 2011
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
R Geraldes, O Ciccarelli, F Barkhof, N De Stefano, C Enzinger, M Filippi, ...
Nature Reviews Neurology 14 (4), 199-213, 2018
Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
EC Tallantyre, L Bĝ, O Al-Rawashdeh, T Owens, CH Polman, JS Lowe, ...
Multiple Sclerosis Journal 16 (4), 406-411, 2010
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions
N Evangelou, GC DeLuca, T Owens, MM Esiri
Brain 128 (1), 29-34, 2005
A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions
EC Tallantyre, PS Morgan, JE Dixon, A Al-Radaideh, MJ Brookes, ...
Investigative radiology 44 (9), 491-494, 2009
Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI
EC Tallantyre, MJ Brookes, JE Dixon, PS Morgan, N Evangelou, ...
Neurology 70 (22), 2076-2078, 2008
Spinal cord gray matter demyelination in multiple sclerosis—a novel pattern of residual plaque morphology
CP Gilmore, L Bö, T Owens, J Lowe, MM Esiri, N Evangelou
Brain pathology 16 (3), 202-208, 2006
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
D Cadavid, M Mellion, R Hupperts, KR Edwards, PA Calabresi, J Drulović, ...
The Lancet Neurology 18 (9), 845-856, 2019
Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis
T Sinnecker, MA Clarke, D Meier, C Enzinger, M Calabrese, N De Stefano, ...
JAMA neurology 76 (12), 1446-1456, 2019
The system can't perform the operation now. Try again later.
Articles 1–20